HR. 5160Reported
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Reauthorizes stem cell therapeutic and research programs through an amended measure ordered reported by committee
Plain-English overview
What this bill does
Reauthorizes stem cell therapeutic and research programs through an amended measure ordered reported by committee
Key points
- Extend stem cell research programs
Current status
Where it stands
Status
Reported
Latest action
2026-05-21 — Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Related context
Topics and policy areas
undefinedBiological and life sciencesBlood and blood diseasesCell biology and embryologyHealthHealth programs administration and fundingOrgan and tissue donation and transplantation